Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 712

1.

Bupropion-Induced Nightmares Treated With Clonidine.

Mathews M, Mathews N, Jamal F, Papa-Molter A.

Prim Care Companion CNS Disord. 2019 Oct 3;21(5). pii: 17l02252. doi: 10.4088/PCC.17l02252. No abstract available.

2.

Practice patterns among early-career primary care (ECPC) physicians and workforce planning implications: protocol for a mixed methods study.

Lavergne MR, Goldsmith LJ, Grudniewicz A, Rudoler D, Marshall EG, Ahuja M, Blackie D, Burge F, Gibson RJ, Glazier RH, Hawrylyshyn S, Hedden L, Hernandez-Lee J, Horrey K, Joyce M, Kiran T, MacKenzie A, Mathews M, McCracken R, McGrail K, McKay M, McPherson C, Mitra G, Sampalli T, Scott I, Snadden D, Murphy GT, Wong ST.

BMJ Open. 2019 Sep 24;9(9):e030477. doi: 10.1136/bmjopen-2019-030477.

3.

Evaluation of paliperidone palmitate long-acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia.

Brown B, Turkoz I, Mancevski B, Mathews M.

Early Interv Psychiatry. 2019 Sep 13. doi: 10.1111/eip.12868. [Epub ahead of print]

PMID:
31515972
4.

Neurocysticercosis Among Zambian Children and Adolescents With Human Immunodeficiency Virus: A Geographic Information Systems Approach.

Buda A, Dean O, Adams HR, Mwanza-Kabaghe S, Potchen MJ, Mbewe EG, Kabundula PP, Moghaddam SM, Mweemba M, Matoka B, Mathews MM, Birbeck GL, Bearden DR.

Pediatr Neurol. 2019 Aug 6. pii: S0887-8994(19)30491-6. doi: 10.1016/j.pediatrneurol.2019.07.017. [Epub ahead of print]

PMID:
31492585
5.

Dynamic risk prediction for diabetes using biomarker change measurements.

Parast L, Mathews M, Friedberg MW.

BMC Med Res Methodol. 2019 Aug 14;19(1):175. doi: 10.1186/s12874-019-0812-y.

6.

A post hoc analysis on hospitalization risk in Asian patients with schizophrenia switching to once-monthly paliperidone palmitate from oral antipsychotics.

Li N, Zhuo JM, Turkoz I, Mathews M, Feng Y, Tan W.

Expert Opin Pharmacother. 2019 Nov;20(16):2033-2039. doi: 10.1080/14656566.2019.1650022. Epub 2019 Aug 8.

PMID:
31393186
7.

Explanatory models of mental illness among family caregivers of persons in psychiatric rehabilitation services: A pilot study.

Mathews M, Bhola P, Herbert H, Chaturvedi SK.

Int J Soc Psychiatry. 2019 Nov;65(7-8):589-602. doi: 10.1177/0020764019866228. Epub 2019 Aug 6.

PMID:
31385555
8.

Research evidence is essential for the development of family medicine as a discipline in the Japanese healthcare system.

Kaneko M, Oishi A, Matsui Y, Miyachi J, Aoki T, Mathews M.

BJGP Open. 2019 Jul 23;3(2). pii: bjgpopen19X101650. doi: 10.3399/bjgpopen19X101650. Print 2019 Jul. No abstract available.

9.

Improving paediatric epilepsy management at the first level of care: a pilot education intervention for clinical officers in Zambia.

Patel AA, Wibecan L, Tembo O, Kalyelye P, Mathews M, Ciccone O.

BMJ Open. 2019 Jul 24;9(7):e029322. doi: 10.1136/bmjopen-2019-029322.

10.

Effect of primary health care reforms in the province of Newfoundland and Labrador: Interrupted time-series analysis.

Knight JC, Moineddin R, Mathews M, Aubrey-Bassler K.

Can Fam Physician. 2019 Jul;65(7):e296-e304.

11.

Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species.

Thompson CG, Rosen EP, Prince HMA, White N, Sykes C, de la Cruz G, Mathews M, Deleage C, Estes JD, Charlins P, Mulder LR, Kovarova M, Adamson L, Arora S, Dellon ES, Peery AF, Shaheen NJ, Gay C, Muddiman DC, Akkina R, Garcia JV, Luciw P, Kashuba ADM.

Sci Transl Med. 2019 Jul 3;11(499). pii: eaap8758. doi: 10.1126/scitranslmed.aap8758.

PMID:
31270274
12.

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia.

Mathews M, Gopal S, Nuamah I, Hargarter L, Savitz AJ, Kim E, Tan W, Soares B, Correll CU.

Neuropsychiatr Dis Treat. 2019 May 21;15:1365-1379. doi: 10.2147/NDT.S197225. eCollection 2019. Review.

13.

Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies.

Savitz AJ, Xu H, Gopal S, Nuamah I, Mathews M, Soares B.

Braz J Psychiatry. 2019 Apr 15. pii: S1516-44462019005007105. doi: 10.1590/1516-4446-2018-0153. [Epub ahead of print]

14.

Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation.

Nash AI, Turkoz I, Savitz AJ, Mathews M, Kim E.

Neuropsychiatr Dis Treat. 2019 Mar 22;15:731-737. doi: 10.2147/NDT.S194264. eCollection 2019.

15.

Effects of NMDA antagonist dizocilpine (MK-801) are modulated by the number of distractor stimuli in the rodent odor span task of working memory.

Galizio M, Deal M, Mathews M, Panoz-Brown D, Prichard A, Bruce KE.

Neurobiol Learn Mem. 2019 May;161:51-56. doi: 10.1016/j.nlm.2019.03.004. Epub 2019 Mar 9.

PMID:
30862525
16.

Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study.

Kane JM, Correll CU, Delva N, Gopal S, Savitz A, Mathews M.

J Clin Psychopharmacol. 2019 Mar/Apr;39(2):180-182. doi: 10.1097/JCP.0000000000001019. No abstract available.

17.

National racial/ethnic and geographic disparities in experiences with health care among adult Medicaid beneficiaries.

Martino SC, Mathews M, Agniel D, Orr N, Wilson-Frederick S, Ng JH, Ormson AE, Elliott MN.

Health Serv Res. 2019 Feb;54 Suppl 1:287-296. doi: 10.1111/1475-6773.13106. Epub 2019 Jan 9.

PMID:
30628052
18.

Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate.

Mathews M, Nuamah I, Savitz AJ, Hough DW, Najarian D, Kim E, Gopal S.

Neuropsychiatr Dis Treat. 2018 Oct 25;14:2807-2816. doi: 10.2147/NDT.S175364. eCollection 2018.

19.

Hiccups With Dose Titration of Aripiprazole.

Mathews M, Mathews N, Menon N, Ahmad R, Papa-Molter A.

Prim Care Companion CNS Disord. 2018 Nov 22;20(6). pii: 17l02251. doi: 10.4088/PCC.17l02251. No abstract available.

20.

Generalized identity in a successive matching-to-sample procedure in rats: Effects of number of exemplars and a masking stimulus.

Galizio M, Mathews M, Prichard A, Bruce KE.

J Exp Anal Behav. 2018 Nov;110(3):366-379. doi: 10.1002/jeab.483.

PMID:
30431658
21.

National Testing of the Emergency Department Patient Experience of Care Discharged to Community Survey and Implications for Adjustment in Scoring.

Parast L, Mathews M, Tolpadi A, Elliott M, Flow-Delwiche E, Becker K.

Med Care. 2019 Jan;57(1):42-48. doi: 10.1097/MLR.0000000000001005.

PMID:
30363023
22.

Determining Student Food Insecurity at Memorial University of Newfoundland.

Blundell L, Mathews M, Bowley C, Roebothan B.

Can J Diet Pract Res. 2019 Mar 1;80(1):14-21. doi: 10.3148/cjdpr-2018-026. Epub 2018 Oct 3.

PMID:
30280913
23.

Shifting From Passive Quality Reporting to Active Nudging to Influence Consumer Choice of Health Plan.

Haviland AM, Damberg CL, Mathews M, Paddock SM, Elliott MN.

Med Care Res Rev. 2018 Sep 26:1077558718798534. doi: 10.1177/1077558718798534. [Epub ahead of print]

PMID:
30255721
24.

Adjusting Medicare Advantage star ratings for socioeconomic status and disability.

Sorbero ME, Paddock SM, Damberg CL, Haas A, Kommareddi M, Tolpadi A, Mathews M, Elliott MN.

Am J Manag Care. 2018 Sep 1;24(9):e285-e291.

25.

Factors Associated With Social Isolation Among the Older People in India.

Kotian DB, Mathews M, Parsekar SS, Nair S, Binu VS, Subba SH.

J Geriatr Psychiatry Neurol. 2018 Sep;31(5):271-278. doi: 10.1177/0891988718796338. Epub 2018 Aug 27.

PMID:
30149767
26.

Saudi visa trainees called home from Canada in diplomatic dispute.

Mathews M, Bourgeault I.

Lancet. 2018 Sep 8;392(10150):815-816. doi: 10.1016/S0140-6736(18)31950-0. Epub 2018 Aug 20. No abstract available.

PMID:
30139529
27.

Protein Synthesis and Translational Control: A Historical Perspective.

Tahmasebi S, Sonenberg N, Hershey JWB, Mathews MB.

Cold Spring Harb Perspect Biol. 2019 Sep 3;11(9). pii: a035584. doi: 10.1101/cshperspect.a035584. Review.

PMID:
30082466
28.

Translation deregulation in human disease.

Tahmasebi S, Khoutorsky A, Mathews MB, Sonenberg N.

Nat Rev Mol Cell Biol. 2018 Dec;19(12):791-807. doi: 10.1038/s41580-018-0034-x. Review.

PMID:
30038383
29.

Principles of Translational Control.

Hershey JWB, Sonenberg N, Mathews MB.

Cold Spring Harb Perspect Biol. 2019 Sep 3;11(9). pii: a032607. doi: 10.1101/cshperspect.a032607. Review.

PMID:
29959195
30.

Treatment of Visual Disorders in Parkinson Disease.

Savitt J, Mathews M.

Curr Treat Options Neurol. 2018 Jun 23;20(8):30. doi: 10.1007/s11940-018-0519-0. Review.

PMID:
29936554
31.

Translational Control in Virus-Infected Cells.

Stern-Ginossar N, Thompson SR, Mathews MB, Mohr I.

Cold Spring Harb Perspect Biol. 2019 Mar 1;11(3). pii: a033001. doi: 10.1101/cshperspect.a033001. Review.

PMID:
29891561
32.

Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup Analysis.

Mathews M, Pei H, Savitz A, Nuamah I, Hough D, Alphs L, Gopal S.

Clin Drug Investig. 2018 Aug;38(8):695-702. doi: 10.1007/s40261-018-0647-z.

PMID:
29882073
33.

Corrigendum: Reviewing the Role of the Efferent Vestibular System in Motor and Vestibular Circuits.

Mathews MA, Camp AJ, Murray AJ.

Front Physiol. 2018 May 30;9:687. doi: 10.3389/fphys.2018.00687. eCollection 2018.

34.

Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study.

Li H, Li Y, Feng Y, Zhuo J, Turkoz I, Mathews M, Tan W.

Neuropsychiatr Dis Treat. 2018 Apr 26;14:1107-1117. doi: 10.2147/NDT.S157399. eCollection 2018.

35.

Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations.

Russu A, Kern Sliwa J, Ravenstijn P, Singh A, Mathews M, Kim E, Gopal S.

Int J Clin Pract. 2018 Jun;72(6):e13089. doi: 10.1111/ijcp.13089. Epub 2018 Apr 30.

36.

Methodological challenges in indirect treatment comparisons: spotlight on a recent comparison of long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia.

Singh A, Gopal S, Kim E, Mathews M, Kern-Sliwa J, Turkoz I, Wooller A, Berlin J.

Int Clin Psychopharmacol. 2018 Jul;33(4):213-216. doi: 10.1097/YIC.0000000000000215. Erratum in: J Am Acad Orthop Surg Glob Res Rev. 2018 Jul 16;2(7):e033.

37.

An assessment of injection site reaction and injection site pain of 1-month and 3-month long-acting injectable formulations of paliperidone palmitate.

Kern Sliwa J, Savitz A, Nuamah I, Mathews M, Gopal S, Elefant E, Najarian D, Alphs L.

Perspect Psychiatr Care. 2018 Oct;54(4):530-538. doi: 10.1111/ppc.12267. Epub 2018 Feb 14.

PMID:
29446084
38.

Effects of N-Methyl-D-aspartate (NMDA) antagonists ketamine, methoxetamine, and phencyclidine on the odor span test of working memory in rats.

Mathews MJ, Mead RN, Galizio M.

Exp Clin Psychopharmacol. 2018 Feb;26(1):6-17. doi: 10.1037/pha0000158.

39.

Heading in the right direction: the importance of direction selectivity for cerebellar motor learning.

Mathews MA, Mohammed Ali F, Wijesinghe R, Camp AJ.

J Physiol. 2018 Jan 15;596(2):139-141. doi: 10.1113/JP275441. Epub 2017 Dec 28. No abstract available.

40.

Once-monthly injection of paliperidone palmitate in patients with recently diagnosed and chronic schizophrenia: a post-hoc comparison of efficacy and safety.

Si T, Zhuo J, Turkoz I, Mathews M, Tan W, Feng Y.

Expert Opin Pharmacother. 2017 Dec;18(17):1799-1809. doi: 10.1080/14656566.2017.1401608. Epub 2017 Nov 15.

PMID:
29141463
41.

Paliperidone Palmitate Improves and Maintains Functioning in Asia-Pacific Patients with Schizophrenia.

Zhang H, Turkoz I, Zhuo J, Mathews M, Tan W, Feng Y.

Adv Ther. 2017 Nov;34(11):2503-2517. doi: 10.1007/s12325-017-0638-0. Epub 2017 Nov 3.

42.

Electrically Tunable Soft Photonic Gel Formed by Blue Phase Liquid Crystal for Switchable Color-Reflecting Mirror.

Sridurai V, Mathews M, Yelamaggad CV, Nair GG.

ACS Appl Mater Interfaces. 2017 Nov 15;9(45):39569-39575. doi: 10.1021/acsami.7b10952. Epub 2017 Nov 2.

PMID:
29067801
43.

The Impact of Access Barriers on Fertility Treatment Decision Making: A Qualitative Study From the Perspectives of Patients and Service Providers.

Maxwell E, Mathews M, Mulay S.

J Obstet Gynaecol Can. 2018 Mar;40(3):334-341. doi: 10.1016/j.jogc.2017.08.025. Epub 2017 Oct 20.

PMID:
29066016
44.

The role of patient and physician advocacy in reducing wait times for cancer care: a qualitative analysis.

Mathews M, Bulman D, Ryan D.

CMAJ Open. 2017 Oct 17;5(4):E773-E778. doi: 10.9778/cmajo.20170039.

45.

Regulation of gene expression by translation factor eIF5A: Hypusine-modified eIF5A enhances nonsense-mediated mRNA decay in human cells.

Hoque M, Park JY, Chang YJ, Luchessi AD, Cambiaghi TD, Shamanna R, Hanauske-Abel HM, Holland B, Pe'ery T, Tian B, Mathews MB.

Translation (Austin). 2017 Aug 14;5(2):e1366294. doi: 10.1080/21690731.2017.1366294. eCollection 2017.

46.

Examination outcomes and work locations of international medical graduate family medicine residents in Canada.

Mathews M, Kandar R, Slade S, Yi Y, Beardall S, Bourgeault I.

Can Fam Physician. 2017 Oct;63(10):776-783.

47.

Relation between family physician retention and avoidable hospital admission in Newfoundland and Labrador: a population-based cross-sectional study.

Knight JC, Mathews M, Aubrey-Bassler K.

CMAJ Open. 2017 Oct 6;5(4):E746-E752. doi: 10.9778/cmajo.20170007.

48.

Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.

Szegedi A, Durgam S, Mackle M, Yu SY, Wu X, Mathews M, Landbloom RP.

Am J Psychiatry. 2018 Jan 1;175(1):71-79. doi: 10.1176/appi.ajp.2017.16040419. Epub 2017 Sep 26.

PMID:
28946761
49.

Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.

Khoury T, Zirpoli G, Cohen SM, Geradts J, Omilian A, Davis W, Bshara W, Miller R, Mathews MM, Troester M, Palmer JR, Ambrosone CB.

Am J Clin Pathol. 2017 Aug 1;148(2):108-118. doi: 10.1093/ajcp/aqx053.

50.

Amnestic drugs in the odor span task: Effects of flunitrazepam, zolpidem and scopolamine.

Galizio M, Mathews M, Mason M, Panoz-Brown D, Prichard A, Soto P.

Neurobiol Learn Mem. 2017 Nov;145:67-74. doi: 10.1016/j.nlm.2017.09.006. Epub 2017 Sep 8.

Supplemental Content

Loading ...
Support Center